Is adenocarcinoma/ large cell carcinoma the most radiocurable type of cancer of the lung? Int J Radiat Oncol Biol Phys 1986; 12: 1801- 5.Cox JD, Barber-Derus S, Hartz AJ, et al.: Is adenocarcinoma/ large cell carcinoma the most radiocurable type of cancer of the lung? Int j Radiat...
high NE scores. Besides these NE/glial tumors, a small number of high NE-score samples were observed for bladder urothelial carcinoma (BLCA), breast invasive carcinoma (BRCA), lung adenocarcinoma (LUAD), lung squamous cell carcinoma (LUSC), pancreatic adenocarcinoma (PDAC) and stomach adenocarcino...
Non-small cell lung cancer:Cancer of the lung which is not of the small cellcarcinoma(oat cell carcinoma) type. The term "non-small cell lung cancer" applies to the various types of bronchogenic carcinomas (those arising from the lining of the bronchi) which includeadenocarcinoma, squamous ce...
We further demonstrate that lurbinectedin, either as a single agent or in combination with osimertinib, causes an appreciable anti-tumor response in multiple models of EGFR-mutant lung adenocarcinoma with histologic transformation to SCLC. Transcriptomic analysis identified induction of apoptosis, ...
The T cell differentiation landscape is shaped by tumour mutations in lung cancer Article 22 May 2020 Somatic copy number alteration predicts clinical benefit of lung adenocarcinoma patients treated with cytokine-induced killer plus chemotherapy Article Open access 12 January 2022 Single-cell sequenc...
The impact and role of EGFR gene mutation on non-small cell lung cancer the presence of two independent pathways for the development of adenocarcinoma; however, the relationship between mutation and epigenetic alteration is not ... S Toyooka,J Soh,H Shigematsu,... - 《Cancer Chemotherapy & Pha...
A indicates adenocarcinoma; S, squamous cell carcinoma. IHC: when multiple intensity values are present in the same sample, the respective percentages of positive cells are separated by a comma. na indicates not available because of Ki67-negative staining. Met FISH is scored as described in Materi...
Emerging drugs for non-small cell lung cancer. Lung cancer is the leading cause of cancer death in the world. Therapeutic improvements caused by recent cytotoxic agents seem to have reached a plateau. N... F Cappuzzo,S Bartolini,L Crinò - 《Expert Opin Emerg Drugs》 被引量: 96发表: 200...
Non-small cell lung cancer (NSCLC), the leading cause of cancer-related deaths, is responsible for estimated 1.6 million deaths as of the year 20121,2. Lung adenocarcinoma is the most common type of NSCLC3, highlighting the urgent need for novel therapeutic approaches. ...
Epidermal growth factor receptor (EGFR) mutations are major drivers of oncogenic alterations that account for an important molecular subtype of lung adenocarcinoma, comprising 40–60% of cases in the South-East Asian population and 10–20% among Caucasian patients1. Patients with lung cancer with se...